Market Overview
India's respiratory devices market covers a broad range of products including ventilators, continuous positive airway pressure (CPAP) devices, nebulizers, oxygen concentrators, respiratory masks, and monitoring equipment used across hospitals, homecare settings, and ambulatory care. The market sits within the larger Asia Pacific medical device sector and reflects India's growing burden of chronic respiratory diseases driven by pollution, smoking, and occupational hazards.
- •Market valued at approximately $1.26 billion in 2025, with various industry sources citing figures between $887 million and $1.5 billion depending on product scope
- •The respiratory monitoring sub-segment alone was valued at $752.11 million in 2024 and is projected to reach $1.12 billion by 2030
- •Critical care ventilators represent a significant sub-market, valued at $400 million in 2024 with an estimated CAGR of 8.12% through 2030
Growth Drivers
The market's expansion is propelled by India's escalating burden of respiratory diseases linked to high air pollution levels, rising tobacco use, and increasing occupational exposure to industrial pollutants. An aging population is also contributing to higher prevalence of chronic obstructive pulmonary disease (COPD), asthma, and sleep-disordered breathing conditions requiring long-term respiratory management.
- •Aging demographics and rising respiratory disorder prevalence cited as primary demand catalysts across multiple industry analyses
- •Government healthcare initiatives including Ayushman Bharat and expanded insurance coverage are improving access to respiratory care in tier-2 and tier-3 cities
- •Advancements in medical device commercialization and technology transfer are accelerating adoption of modern respiratory equipment in domestic healthcare facilities
Segmentation and Regional Analysis
The market is segmented into therapeutic devices such as ventilators and CPAP machines, diagnostic and monitoring equipment, and consumables including masks and tubing. A particularly dynamic segment is digital respiratory devices, which incorporate connected technologies for remote monitoring and are projected to grow at a 31.5% CAGR from 2025 to 2030.
- •Northern and western regions of India lead in market share due to higher healthcare infrastructure density and elevated respiratory disease prevalence
- •The digital respiratory devices segment, starting from a 2024 base valued at approximately $2.23 billion for connected technologies, is forecast at 31.5% CAGR through 2030
- •Product categories include ventilators, nebulizers, oxygen concentrators, humidifiers, masks, and respiratory monitoring systems used in ICU, homecare, and ambulatory settings
Trends and Outlook
What are the recent trends and outlook?
The market is moving toward greater digital integration, with smart ventilators, connected CPAP devices, and telemedicine-enabled respiratory monitoring gaining prominence. Government push for indigenous medical device manufacturing under the Production Linked Incentive scheme is expected to reshape supply chains and pricing dynamics over the forecast period.
- •Digital and connected respiratory technologies represent the fastest-growing segment, driven by telemedicine adoption and remote patient monitoring demand
- •Growing preference for home-based respiratory care, particularly for sleep apnea and chronic COPD management, is expanding the homecare device segment
- •The combined anesthesia and respiratory devices market in India is projected to reach $1.31 billion by 2030, reflecting sustained institutional demand from expanding hospital infrastructure
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.